|

Seltorexant Clinical Trials

1 actively recruiting trial across 1 location

Also known as: JNJ 42847922

Pipeline

Phase 3: 1

Top Sponsors

  • Janssen Research & Development, LLC1

Indications

  • Depression1
  • Depressive Disorder, Major1

Birmingham, Alabama1 trial

Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms

University of Alabama at Birmingham

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.